buformin has been researched along with Cancer of Cervix in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buformin is an old anti-diabetic agent and manifests potent anti-tumor activities in several malignancies." | 1.48 | Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel. ( Chen, L; Li, J; Liu, Q; Tang, M; Wang, Y; Yu, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Chen, L | 1 |
| Liu, Q | 1 |
| Tang, M | 1 |
| Wang, Y | 1 |
| Yu, J | 1 |
1 other study available for buformin and Cancer of Cervix
| Article | Year |
|---|---|
Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Buformin; Cell Proliferation; Fema | 2018 |